Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-20-000213
Filing Date
2020-02-14
Accepted
2020-02-14 09:02:30
Documents
2
Group Members
SCHONFELD STRATEGIC ADVISORS LLC

Document Format Files

Seq Description Document Type Size
1 e619344_sc13ga-pt.htm SC 13G/A 68676
2 e619344_ex99-a.htm EX-99.(A) 3155
  Complete submission text file 0001193805-20-000213.txt   73596
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Subject) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80327 | Film No.: 20614374
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 2 JERICHO PLAZA SUITE 300 JERICHO NY 11753
Business Address 2 JERICHO PLAZA SUITE 300 JERICHO NY 11753 5169422483
Sassicaia Capital Advisers LLC (Filed by) CIK: 0001692751 (see all company filings)

EIN.: 814255954 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A